Treace Medical Concepts (TMCI) Accumulated Expenses (2020 - 2026)

Treace Medical Concepts (TMCI) has 7 years of Accumulated Expenses data on file, last reported at $6.0 million in Q1 2026.

• Quarterly Accumulated Expenses rose 15.18% year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (up 15.18% YoY) and the FY2025 annual result came in at $5.8 million, down 12.03% from the prior year.
• Accumulated Expenses grew to $6.0 million in Q1 2026, from $5.8 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $15.2 million in Q1 2024 to a low of $398000.0 in Q3 2023.
• A 5-year average of $5.0 million and a median of $5.2 million in 2025 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2023 — Accumulated Expenses tumbled 94.56% — and 2025, when it jumped 1635.63%.
• Tracing TMCI's Accumulated Expenses over 5 years: stood at $7.7 million in 2022, then plunged by 94.56% to $417000.0 in 2023, then surged by 1476.74% to $6.6 million in 2024, then dropped by 12.03% to $5.8 million in 2025, then climbed by 3.35% to $6.0 million in 2026.
• The last three Accumulated Expenses figures came in at $6.0 million (Q1 2026), $5.8 million (Q4 2025), and $413000.0 (Q3 2025), per Business Quant data.